We are live on
!
Find out more
HCA
Horan Capital Advisors Portfolio holdings
AUM
$297M
1-Year Est. Return
9.75%
This Fund
S&P 500
This Quarter
Est. Return
+3.35%
1 Year Est. Return
+9.75%
3 Year Est. Return
+26.64%
5 Year Est. Return
+133.08%
10 Year Est. Return
+224.36%
AUM
$149M
AUM Growth
-$9.34M
(-5.9%)
Cap. Flow
-$13M
Cap. Flow
% of AUM
-8.72%
Top 10 Holdings %
Top 10 Hldgs %
37.84%
Holding
266
New
2
Increased
9
Reduced
46
Closed
195
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$2.14M |
| 2 |
Walt Disney
DIS
|
+$852K |
| 3 |
CVS Health
CVS
|
+$808K |
| 4 |
Corteva
CTVA
|
+$452K |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$89.3K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.95M |
| 2 |
Viatris
VTRS
|
+$862K |
| 3 |
DuPont de Nemours
DD
|
+$820K |
| 4 |
Schwab International Equity ETF
SCHF
|
+$357K |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$283K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.54% |
| 2 | Financials | 12.26% |
| 3 | Communication Services | 12.04% |
| 4 | Healthcare | 10.07% |
| 5 | Industrials | 8.61% |
Similar funds
WGCA
RAM
WFA
PPWP
RI
BCM
IAM
UFA
Horan Capital Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Horan Capital Advisors held 266 positions worth $149M, down 5.9% from $158M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Horan Capital Advisors withdrew a net $13M in Q2 2019, closing 195 positions and reducing 46 holdings. Its most notable exit was Celgene Corp, an estimated $1.95M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Horan Capital Advisors opened a new position in Dow Inc worth $2M.
- Horan Capital Advisors's largest Q2 2019 buy was Dow Inc: 40,578 shares worth $2M.
- Horan Capital Advisors added most to Walt Disney in Q2 2019, an estimated $852K increase.
- Horan Capital Advisors's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $820K.
- Horan Capital Advisors fully exited Celgene Corp in Q2 2019, selling an estimated $1.95M.
- Horan Capital Advisors's ten largest holdings make up 38% of its $149M portfolio in Q2 2019.
- Horan Capital Advisors opened 2 new positions and closed 195 in Q2 2019.
- Horan Capital Advisors's portfolio value fell 5.9% quarter-over-quarter to $149M.
Based on Horan Capital Advisors's 13F filing for Q2 2019, filed 26 Jul 2019.